Stonebridge Capital Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-400
Closed -$14.8K – 936
2023
Q2
$14.8K Hold
400
– – ﹤0.01% 552
2023
Q1
$12K Hold
400
– – ﹤0.01% 586
2022
Q4
$12.2K Sell
400
-246
-38% -$7.38K ﹤0.01% 568
2022
Q3
$16K Buy
646
+421
+187% +$13.9K ﹤0.01% 503
2022
Q2
$7K Hold
225
– – ﹤0.01% 652
2022
Q1
$7K Hold
225
– – ﹤0.01% 717
2021
Q4
$8K Hold
225
– – ﹤0.01% 663
2021
Q3
$7K Hold
225
– – ﹤0.01% 666
2021
Q2
$8K Sell
225
-275
-55% -$9.11K ﹤0.01% 636
2021
Q1
$14K Buy
+500
New +$13.3K ﹤0.01% 567
2020
Q3
– Sell
-1,800
Closed -$28K – 260
2020
Q2
$28K Hold
1,800
– – 0.01% 355
2020
Q1
$16K Sell
1,800
-8,210
-82% -$118K ﹤0.01% 414
2019
Q4
$181K Buy
10,010
+10,000
+100,000% +$166K 0.03% 191
2019
Q3
$0 Hold
10
– – ﹤0.01% 871
2019
Q2
$0 Buy
+10
New +$295 ﹤0.01% 898

Other funds holding CC

Stonebridge Capital Advisors's CC Position: Q3 2023 in Review

Stonebridge Capital Advisors sold out of Chemours (CC) in Q3 2023, closing a stake of 400 shares — an estimated $14.8K sold.

Stonebridge Capital Advisors first reported a position in CC in Q2 2019 and held it in 15 quarters. The position peaked at $181K in Q4 2019. 455 funds tracked by Wall St. Rank hold CC as of Q3 2023.

  • Stonebridge Capital Advisors reported no remaining Chemours position as of Q3 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 400 Chemours shares in Q3 2023, an estimated $14.8K.
  • Stonebridge Capital Advisors first reported a position in Chemours in Q2 2019 and held it in 15 quarters.
  • Stonebridge Capital Advisors's Chemours position peaked at $181K in Q4 2019.
  • 455 funds tracked by Wall St. Rank held Chemours as of Q3 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.